Large Volume Parenteral Market size was valued at USD 9.26 Billion in 2019 and is projected to reach USD 18.29 Billion by 2027, growing at a CAGR of 8.88% from 2020 to 2027.
The global large volume parenteral (LVP) market size was valued at USD 9.5 billion in 2021 and is projected to reach around USD 15.0 billion in 2030 exhibiting a CAGR of 6.0% in the forecasted period. The increasing prevalence of malnutrition, rising natality rate, and increasing premature births worldwide are fuelling the market growth. Apart from this, the increasing consumption of fast food across the world has resulted in growing instances of non-communicable diseases, such as diabetes, hypertension, obesity, and other metabolic disorders. This is positively impelling the adoption of LVPs that are a mixture of dextrose, lipids, amino acids, trace metals, added electrolytes, and vitamins.
A large volume parenteral (LVP) is a single-dose injection that has been sterilised using heat and is then packaged in a glass bottle or flexible container with a capacity of more than 100ml. To administer the active drug compounds directly into the blood vessels, organs, tissues, or lesions, an injection must be administered through the skin or another external boundary tissue. A water-miscible or non-aqueous vehicle, an active component, and optional additives including buffers, antioxidants, preservatives, surfactants, antibacterial agents, and tonicity adjusters are all typically included. Peritoneal dialysis, irrigating solutions, blood derivatives, medication premixes, and contrast agents are a few of the LVPs that are frequently accessible globally.
Aqueous solutions known as large volume parenteral (LPVs) are given in doses of at least 100 ml in 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml containers. Large volume injections are another name for LPVs. Parenteral formulations are sterile liquid or solid dose forms that can be delivered intravenously, subcutaneously, or intramuscularly. Parenteral medications have a high bioavailability and effectiveness. In a large number of cases, it is preferred to oral dosages.
Market Trends:
One of the main drivers of the demand for LVPs to provide a high amount of nutrients to patients who are unable to take food orally is the rising prevalence of malnutrition, rising natality rate, and rising premature births globally. In addition, they are frequently utilised to provide vital nutrients to patients receiving treatment for esophageal blockage, GI disorders, cancer, and ulcers. LVPs are also widely used in heart surgery to avoid restricting blood flow and ischemic damage to the myocardium after reperfusion. This is helping the market expand along with the rising demand for quick, efficient, and safe ways to provide medications to patients undergoing surgical procedures. In addition, the consumption of fast food is rising globally.
Request to Download Sample of This Strategic Report https://analyticsmarketresearch.com/sample-request/large-volume-parenteral-market/10387/
Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions policies to gain a competitive edge and expand their product portfolio & business footmark. The ongoing COVID-19 pandemic hindered the healthcare systems globally and driven market players to update products for unexploited prospects. Some of the key players operating in the global large volume parenteral market include:
• Albert David Ltd.
• B. Braun Melsungen AG
• Baxter
• BML Parenteral Drugs
• Fresenius Kabi AG
• Grifols, S.A.
• Pfizer, Inc.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Cipla Inc.
• Zydus Group
• ALTHEA
• Other players
Segments
By Type
• Soft Bag LVP
• Plastic Bag LVP
• Glass Bottle LVP
By Volume
• 250 ml – 500 ml
• 100 ml-250 ml
• 500 ml – 1000 ml
• 1000 ml – 2000 ml
• 2000 ml and More
By Application
• Fluid Balance Injections
• Nutritious Injections
• Therapeutic Injections
By End User
• Hospitals
• Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
For more information about this report visit:- https://analyticsmarketresearch.com/reports/large-volume-parenteral-market/10387/
Frequently Asked Questions About This Report
- How big is the India large volume parenteral market?
- What is India’s large volume parenteral market growth?
- Which segment accounted for the largest India large volume parenteral market share?
- Who are the key players in India’s large volume parenteral market?
- What are the factors driving the India large volume parenteral market?
- Which application segment accounted for the largest share in the India large volume parenteral market?
- In terms of volume, which segment led the India large volume parenteral market?
